Language Select
Varian Logo

Press Releases

April 19, 2018
Varian (NYSE: VAR) today announced it is incorporating new imaging technologies in the Halcyon™ 2.0 treatment system to expand its capabilities and ability to deliver high quality cancer care... Read more
April 18, 2018
Varian (NYSE: VAR) today announced it received the "Best After-Sales Service Performance Award for Radiotherapy Products" in the annual Chinese Medical Devices Industry Data and After-Sales... Read more
April 09, 2018
Varian (NYSE: VAR) today announced a new version of its Velocity™ cancer imaging software which includes Rapidsphere™, a module for Y90 Selective Internal Radiation Therapy (SIRT) dosimetry... Read more
March 27, 2018
Varian (NYSE: VAR) today announced customers using Varian Eclipse™ treatment planning software placed the highest in the overall category in the first ever World Championships of Treatment... Read more
March 20, 2018
Varian (NYSE: VAR) announced PTC St. Petersburg Center of Nuclear Medicine of the Sergey Berezin Medical Institute successfully completed its first pediatric patient treatment with the Varian... Read more
March 14, 2018
Varian (NYSE: VAR) today announced it has received clearances from the U.S. antitrust authorities and the German Federal Cartel Office (FCO) on the proposed acquisition of all of the outstanding... Read more
March 12, 2018
Varian (NYSE: VAR) today announced that it will report results for the second quarter of fiscal year 2018 after market close on Wednesday, April 25, 2018. The news release will be followed by a... Read more
March 09, 2018
Varian (NYSE: VAR) has been selected by the Instituto Mexicano del Seguro Social (IMSS) to equip seven treatment centers across Mexico with modern radiotherapy treatment systems, including the... Read more
March 05, 2018
Varian (NYSE: VAR) and the University of Maryland School of Medicine (UMSOM) announced today they have reached their first educational milestone at the Maryland Proton Treatment Center (MPTC):... Read more
March 01, 2018
Varian (NYSE: VAR) today announced that Gary Bischoping, chief financial officer, and J. Michael Bruff, senior vice president of investor relations, will present at the Barclays Global Healthcare... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com

Monica Prokocki
Director, Investor Relations
650.424.5184
investors@varian.com